Doximity’s stock surges on medical AI excitement as analysts debate long-term risks

Doximity, the professional network for physicians, saw its stock explode following fiscal first-quarter 2027 results released on August 6, 2026. Shares more than doubled in premarket trading before settling to close the day with roughly 43% gains. For a company whose stock had been cut in half year-to-date before the announcement, that’s the kind of reversal that makes portfolio managers spill their coffee. The catalyst was straightforward: AI adoption numbers that actually looked impressive. Doximity reported close to 300,000 quarterly active users on its suite, and nearly half of US doctors at the company’s client hospitals are now engaging with its workflow and scheduling AI tools. From networking site to AI platform Doximity has long been described as “LinkedIn for doctors,” a framing that probably undersells what the company has been building. The platform connects over a million medical professionals and has increasingly layered AI-powered tools on top of that network, including clinical decision support, automated scheduling, and documentation assistance. The company’s AI credentials got a notable boost in July 2026 when a Stanford-Harvard clinical safety study ranked Doximi...